The Procter and Gamble Co., Miami Valley Innovation Center, 11810 East Miami River Road, Cincinnati, OH 45252, USA.
Mutat Res. 2012 Jun 14;745(1-2):38-50. doi: 10.1016/j.mrgentox.2012.03.012. Epub 2012 Apr 6.
While the collection of genotoxicity data and insights into potential mechanisms of action for nano-sized particulate materials (NPs) are steadily increasing, there is great uncertainty whether current standard assays are suitable to appropriately characterize potential risks. We investigated the effects of NPs in an in vivo Comet/micronucleus (MN) combination assay and in an in vitro MN assay performed with human blood. We also incorporated additional endpoints into the in vivo study in an effort to delineate primary from secondary mechanisms. Amorphous silica NPs (15 and 55 nm) were chosen for their known reactivity, while gold nano/microparticles (2, 20, and 200 nm) were selected for their wide size range and lower reactivity. DNA damage in liver, lung and blood cells and micronuclei in circulating reticulocytes were measured after 3 consecutive intravenous injections to male Wistar rats at 48, 24 and 4h before sacrifice. Gold nano/microparticles were negative for MN induction in vitro and in vivo, and for the induction of DNA damage in all tissues. Silica particles, however, caused a small but reproducible increase in DNA damage and micronucleated reticulocytes when tested at their maximum tolerated dose (MTD). No genotoxic effects were observed at lower doses, and the in vitro MN assay was also negative. We hypothesize that silica NPs initiate secondary genotoxic effects through release of inflammatory cell-derived oxidants, similar to that described for crystalline silica (quartz). Such a mechanism is supported by the occurrence of increased neutrophilic infiltration, necrosis, and apoptotic cells in the liver, and induction of inflammatory markers TNF-α and IL-6 in plasma at the MTDs. These results were fairly consistent between silica NPs and the quartz control, thereby strengthening the argument that silica NPs may act in a similar, thresholded manner. The observed profile is supportive of a secondary genotoxicity mechanism that is driven by inflammation.
尽管越来越多的研究致力于收集纳米颗粒材料(NPs)的遗传毒性数据并深入了解其潜在作用机制,但目前的标准检测方法是否适用于适当评估潜在风险仍然存在很大的不确定性。我们研究了 NPs 在体内彗星/微核(MN)组合试验和人血中进行的体外 MN 试验中的作用,并在体内研究中纳入了其他终点,以努力区分原发性和继发性机制。选择无定形二氧化硅 NPs(15 和 55nm)是因为它们已知的反应性,而选择金纳米/微颗粒(2、20 和 200nm)是因为它们的尺寸范围广且反应性较低。在雄性 Wistar 大鼠连续 3 次静脉注射后,在处死前 48、24 和 4 小时分别测量了肝脏、肺和血细胞中的 DNA 损伤以及循环网织红细胞中的微核。金纳米/微颗粒在体外和体内均未诱导 MN,也未在所有组织中诱导 DNA 损伤。然而,当测试其最大耐受剂量(MTD)时,二氧化硅颗粒会导致 DNA 损伤和微核网织红细胞的小但可重复的增加。在较低剂量下未观察到遗传毒性作用,体外 MN 试验也呈阴性。我们假设二氧化硅 NPs 通过释放炎症细胞衍生的氧化剂引发继发性遗传毒性效应,类似于对结晶二氧化硅(石英)的描述。这种机制得到了在 MTD 时肝脏中中性粒细胞浸润、坏死和凋亡细胞增加以及血浆中炎症标志物 TNF-α和 IL-6 诱导的支持。这些结果在二氧化硅 NPs 和石英对照之间相当一致,从而加强了二氧化硅 NPs 可能以类似的、阈值方式起作用的论点。观察到的特征支持炎症驱动的继发性遗传毒性机制。